Time for a lead-time definition? Author response to ‘Why the length of recurrence free survival or “lead-times” can be misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et al. Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis’

• Karen-Lise Garm Spindler,
• Louise Bach Callesen,
• Dirk Arnold

Affiliations

Karen-Lise Garm Spindler

Louise Bach Callesen

Dirk Arnold